Oncology Xagena
Seven of 56 patients with metastatic melanoma showed durability of complete or partial responses ranging from four months to the longest still ongoing at over 34 months, with five of the seven respons ...
An investigational new drug Sutent ( Sunitinib ) more than doubled survival and significantly reduced tumor growth and spread in patients with Imatinib-resistant gastrointestinal stromal tumors ( GIS ...
An experimental compound, ABT-737, that blocks the action of a class of proteins known as the Bcl-2 family, may prove to be a valuable tool in the fight against cancer. The Bcl-2 family of protein ...
Researchers at the University of Michigan Comprehensive Cancer Center found a new technique might allow women diagnosed with cancer the opportunity to have children when chemotherapy and radiation tr ...
Researchers at The Burnham Institute found that a cell-cycle checkpoint protein, known to be activated by an important class of anticancer drugs, may play crucial roles in both the hampering of therap ...
Using a mouse model of breast cancer, researchers from the University of Pennsylvania School of Medicine have shown that Snail, a molecule normally important in embryonic development, can promote brea ...
Researchers at University of California - Los Angeles ( UCLA ) - Jonsson Cancer Center have uncovered the mechanism by which an antibody blocks the growth of prostate cancer in animal models. The a ...
Results from researchers at Harvard Medical School and Massachusetts Institute of Technology ( MIT ) have shown for the first time that targeted drug delivery is possible using nanoparticle-apatamer c ...
Researchers at St. Jude Children's Research Hospital have demonstrated in laboratory studies a new treatment for the pediatric eye cancer, retinoblastoma, that appears to be more effective than the cu ...
Chemotherapy given in low, frequent doses a novel strategy called "metronomic" delivery achieved partial shrinkage of disease in some advanced breast cancer patients when given concurrently with a ...
In a study published in the Journal of Biological Chemistry, researchers at the University of Pittsburgh, report that Aspirin, combined with a promising new cancer therapy known as tumor necrosis fac ...
Researchers at UCLA ( University of California - Los Angeles ) knew - based on two clinical trials - that a subset of kidney cancer patients responded well to an experimental targeted therapy, but the ...
Researchers at Washington University School of Medicine in St. Louis found that inactivating a protein called mammalian Rad9 could make cancer cells easier to kill with ionizing radiation. The rese ...
A study, published in the Clinical Cancer Research, has showed that Botox may have a new use as an adjuvant to cancer therapy, providing an open door for chemotherapy and radiation treatments. The ...
Axel Ullrich, at the Max Planck Institute of Biochemistry in Martinsried, Germany, already showed at the beginning of the 1990s that blocking blood vessel development in a tumour slows down its growth ...
